We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Constellation Healthcare Technologies | LSE:CHT | London | Ordinary Share | CMN SHS USD0.0001 (DI/REG S) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 216.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
01/8/2016 15:53 | Nice 7,500 share buy at 154p, nicely above the 153p published offer price. | rivaldo | |
01/8/2016 14:13 | Many thanx for the clarification... | santangello | |
01/8/2016 14:03 | Santangello, there was stock around for a while, with buying possible at the mid-price or slightly below, but the overhang seems to have been cleared. So now we seem to be back to the norm, which is a tightly held stock. The directors hold almost 60% and L&G own 5.3%, and there must be various others just under 3% following the IPO and subsequent placings. | rivaldo | |
01/8/2016 13:57 | can sell 20,000 at 148.5 way above the quoted 144. think they must be short of stock p.s i wont be selling | mr_benn | |
01/8/2016 12:46 | ....should have added...after my first 5k buy this a.m......MMs moved the NMS to 1k, is there no stock around or is this the norm ?? | santangello | |
01/8/2016 11:45 | Yes, I have been adding, but not in the amounts I want today.....MMs just not letting me have what I want grrrrr !!!! Are these always so hard to buy/tightly held. Being quoted 154.5p and I only want 20k ! | santangello | |
01/8/2016 08:34 | Nice start - 12k of buys at the full offer moving the price up 2.5p. A long way to go here though imho. | rivaldo | |
31/7/2016 08:13 | Indeed so. I'm also invested in SOM, another USA-based company, which has done extremely well. Plus the CEO here has previously bought, turned around and sold US medical billing businesses, so he's done it all before. Finncap are imo going to have to increase their forecasts considerably from 15.22p EPS given currency movements and the trading statement 10 days ago. Good to see a decent £20,000 buy at the full 150p offer price on Friday afternoon. | rivaldo | |
30/7/2016 14:23 | Just checked the listing requirements for Nasdaq and they wouldn't have met them. I'm guessing that might be the answer.. | adamb1978 | |
28/7/2016 07:29 | Yep, it moved up nicely on just a single buy of 2,200 shares! Hopefully this means any overhang has now cleared. | rivaldo | |
27/7/2016 16:32 | Nice finish to the day. | battlebus2 | |
22/7/2016 12:05 | Would love to see them resume the divi.... | deltrotter | |
22/7/2016 10:48 | Good to see the price tick up again on just two buys of 6,500 shares in total. | rivaldo | |
21/7/2016 16:03 | Thanx for the welcome gentlemen. Just sneaked a few more.....be rude not to :) | santangello | |
21/7/2016 14:51 | Yes welcome onboard Santangello, looks like good timing on your purchases but like you say this is a long termer. | battlebus2 | |
21/7/2016 12:27 | Cheers Santangello, and welcome. Nice 25,000 share buy from yesterday just reported late. The share price should now climb steadily in the run-up to the interims in mid-September - and we may also get an acquisition or two before that if all goes well (last year there were two acquisitions in September). | rivaldo | |
21/7/2016 11:34 | Maiden purchases yesterday and today. Nice to see familiar and respected posters/holders from stocks we similarly hold here (Rivaldo/battlebus), which adds to the confidence too. I look forward to a very profitable long hold here. Be interesting to see how todays announcement is reacted to across the Pond ? Good luck to all, happy to be amongst you. | santangello | |
21/7/2016 11:28 | Revenue for the full year expected to be $126 million. That's a 65% increase from the previous year. How much of this drops straight into the bottom line? A considerable amount I'd imagine. | dave2608 | |
21/7/2016 11:01 | Finncap's brief update this morning (thanks mate) confirms that today's revenue figure of $126.5m is ahead of their expectations, which were $125.3m and have evidently been increased since their January note. Forecasts will be reassessed after the H1 results, but there is upside potential from organic wins and acquisitions. The group has $10m net cash and is cash-generative. They "believe that the current low ratings of 8.4x PER and 3.6x EV/EBITDA in FY2016E significantly undervalue the growth potential in the defensive $37bn US medical billings market and the value-creation potential from Constellations model and strategy." | rivaldo | |
21/7/2016 09:56 | A little coverage here, the more the merrier: Http ://www.proactiveinve | rivaldo | |
21/7/2016 08:31 | Agreed guys. | deltrotter | |
21/7/2016 07:18 | Yes it's all looking rather good, at today's rate 126 turnover equates to £95 million. | battlebus2 | |
21/7/2016 07:12 | Excellent trading statement this morning, with everything in line with Board expectations. The outturn for both H1 and the full year looks good. In particular, the RNS notes expected 2016 turnover of more than $126.5m, whereas Finncap's note of 4th January only forecast $121.3m: This could be a very good year indeed. A number of acquisitions are being evaluated too, plus organic growth is coming along nicely. With forecast EPS of 15.22p probably having to be increased 10%-15% on currency translation alone, CHT is imo at least 40%-50% undervalued and possibly a lot more than that given Finncap's 310p target. | rivaldo |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions